A PHASE II III RANDOMIZED STUDY COMPARING EFFICACY OF NOLATREXED (THYMITAQ, AG337) TO DOXORUBICIN IN PATIENTS WITH UNRESECTABLE HEPATOCELLULAR-CARCINOMA (HCC)/
T. Mok et al., A PHASE II III RANDOMIZED STUDY COMPARING EFFICACY OF NOLATREXED (THYMITAQ, AG337) TO DOXORUBICIN IN PATIENTS WITH UNRESECTABLE HEPATOCELLULAR-CARCINOMA (HCC)/, Annals of oncology, 9, 1998, pp. 664-664